Dexcom (DXCM) Inventory (2010 - 2026)

Dexcom (DXCM) has 17 years of Inventory data on file, last reported at $693.6 million in Q1 2026.

• On a quarterly basis, Inventory rose 28.87% year-over-year to $693.6 million in Q1 2026; TTM through Mar 2026 was $693.6 million, a 28.87% increase from a year earlier, with the FY2025 full-year figure at $629.1 million, up 15.94% from the prior year.
• Inventory for Q1 2026 stood at $693.6 million, up from $629.1 million in the prior quarter.
• Over the last five years, Inventory for DXCM reached as high as $693.6 million in Q1 2026 and fell as low as $306.7 million in Q4 2022.
• Historically, Inventory has averaged $498.2 million across 5 years, with a median of $542.6 million in 2024.
• Across the five-year window, Inventory fell 14.16% in 2022 and jumped 82.46% in 2023, its largest moves.
• Year by year, Inventory stood at $306.7 million in 2022, then surged by 82.46% to $559.6 million in 2023, then fell by 3.04% to $542.6 million in 2024, then advanced by 15.94% to $629.1 million in 2025, then climbed by 10.25% to $693.6 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $693.6 million in Q1 2026, $629.1 million in Q4 2025, and $604.1 million in Q3 2025.